drugset / Trial / NCT03219645

Ginkgo Diterpene Lactone Meglumine Injection on Platelet Reactivity in Acute Ischemic Stroke

NCT03219645

RandomizedParallel-groupSingle-blindTreatment

Summary

This study evaluates the addition of Ginkgo Diterpene Lactone Meglumine Injection to aspirin in the treatment of acute ischemic stroke.Half of patient will receive Ginkgo Diterpene Lactone Meglumine Injection(25mg once/day D1-D14) and aspirin(300mg loading dose,then 100mg once/day D2-D14) in combination, while the other half will receive aspirin(300mg loading dose,then 100mg once/day D2-D14).

Timeline

Start
2017-07-15
Primary completion
2017-10-31
Completion
2017-12-31

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ginkgo Diterpene Lactone Meglumine Unknown 25 mg Intravenous
Comparator Aspirin Small molecule 100 mg

Indications